Research Projects & Grants

For Profit Organization

• A long-term, open-label follow-up study of tofacitinib for treatment of juvenile idiopathic arthritis (JIA), Role: Investigator, Pfizer Pharmaceuticals, (05/2022 - 05/2023) Status: Completed
• Efficacy, safety and tolerability of tofacitinib for treatment of polyarticular course juvenile idiopathic arthritis (JIA) in children and adolescent subjects, Role: Investigator, Pfizer Inc., U.S. Pharmaceuticals Group, (10/2018 - 10/2019) Status: Completed
• RAINBOW study: A randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of infants born prematurely with retinopathy of prematurity, Role: Investigator, Novartis Pharmaceuticals Corporation, (02/2018 - 02/2019) Status: Completed

Internal

• Yield of ophthalmologic evaluation in the setting of non-accidental head trauma at a major academic medical center in Southern California, Role: PI, LLU Dept. of Ophthalmology, (09/2020) Status: Approved
• Duration of esotropia and surgical outcomes in accommodative esotropia, Role: PI, LLU Dept. of Ophthalmology, (03/2016) Status: Completed

Non-Profit Organization

• Postnatal Growth and Retinopathy of Prematurity Model Development Study (G-ROP-1), Role: Principal Investigator, Children's Hospital Philadelphia, (09/2012 - 03/2019) Status: Closed

State

• Bright Eyes: Children Vision Screening and Intervention, Role: Co-PD/PI, First 5 (Children & Families Commission) of Riverside County, (02/2011 - 06/2012) Status: Closed